Quratis
Latest round
- Series B
Last raised
- Aug 2018
Total raised
- $25M
Investors
- 8
About Quratis
Founded in 2016 and based in Seoul, South Korea, Quratis Inc. is a biotechnology company that focuses on the R&D of vaccine products, cell therapy platforms, and Peptide nucleic acid (PNA) based antimicrobial agents. The company received phase 2a Investigational New Drug (IND) approval for Tuberculosis (TB) for adults in 2017, and phase 1 IND approval for TB vaccine for adolescents in 2018. And in 2019 the company performed a porcine circovirus vaccine development project and an antibiotic-resistant antimicrobial agent project. And also, the company applied phase 2b/3 IND for TB vaccine for adolescents & adults in December 2021 and was approved in July 2022.92 million shares in Quratis Inc. at KRW 631 apiece, for KRW 5 billion, in a PIPE deal.87% minority stake in the company in total. The company engages in business scope including R&D of vaccines, cell-penetrating peptide technology, and peptide nucleic acid based on antimicrobial agents. The vaccines include the tuberculosis vaccine. The cell-penetrating peptide technology can be used for the R&D of antibiotics, antiviral drugs, and anticancer. The company also provides Contract Development and Manufacturing Organization (CMO & CDMO) services.
Who invested in Quratis
8 investors across 2 rounds
See all investors in Quratis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Quratis
Who invested in Quratis?
Quratis has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Quratis raised?
Quratis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Quratis last raise money?
Quratis's most recent round on record is a Series B, in Aug 2018.
What does Quratis do?
Founded in 2016 and based in Seoul, South Korea, Quratis Inc.
Where is Quratis headquartered?
Quratis is headquartered in Seoul, South Korea.
Which VCs invest in companies like Quratis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Quratis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Quratis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.